This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Arezzo, IT (2017 - 2018)
- Siena, IT (2019 - 2024)
Company Filing History:
Years Active: 2017-2025
Title: Manuele Martinelli: Innovator in Meningococcal Research
Introduction
Manuele Martinelli is a prominent inventor based in Siena, Italy. He has made significant contributions to the field of meningococcal research, holding a total of six patents. His work focuses on enhancing the stability of polypeptides, which is crucial for vaccine development.
Latest Patents
Among his latest patents are the "Modified meningococcal fHbp polypeptides" aimed at increasing stability. This innovation is vital for improving the efficacy of vaccines against meningococcal diseases. The repeated emphasis on stability highlights the importance of this research in the medical field.
Career Highlights
Manuele Martinelli is associated with GlaxoSmithKline Biologicals S.A., a leading company in vaccine development. His role in this organization has allowed him to contribute to groundbreaking research that has the potential to save lives.
Collaborations
Some of his notable coworkers include Maria Scarselli and Matthew Bottomley. Their collaboration has fostered an environment of innovation and excellence in the research they conduct.
Conclusion
Manuele Martinelli's work in the field of meningococcal research exemplifies the impact of innovative thinking in medicine. His patents and collaborations continue to pave the way for advancements in vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile